Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.

Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, Chadwick DR, Clark R, Cosgrove CA, Galloway J, Goodman AL, Heer A, Higham A, Iyengar S, Jeanes C, Kalra PA, Kyriakidou C, Bradley JM, Munthali C, Minassian AM, McGill F, Moore P, Munsoor I, Nicholls H, Osanlou O, Packham J, Pretswell CH, San Francisco Ramos A, Saralaya D, Sheridan RP, Smith R, Soiza RL, Swift PA, Thomson EC, Turner J, Viljoen ME, Fries L, Cho I, McKnight I, Glenn G, Rivers EJ, Robertson A, Alves K, Smith K, Toback S

Open source

DOI
10.1093/cid/ciac803
Published
2023 Feb 8
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciac803,
  title = {Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.},
  author = {Heath PT and Galiza EP and Baxter DN and Boffito M and Browne D and Burns F and Chadwick DR and Clark R and Cosgrove CA and Galloway J and Goodman AL and Heer A and Higham A and Iyengar S and Jeanes C and Kalra PA and Kyriakidou C and Bradley JM and Munthali C and Minassian AM and McGill F and Moore P and Munsoor I and Nicholls H and Osanlou O and Packham J and Pretswell CH and San Francisco Ramos A and Saralaya D and Sheridan RP and Smith R and Soiza RL and Swift PA and Thomson EC and Turner J and Viljoen ME and Fries L and Cho I and McKnight I and Glenn G and Rivers EJ and Robertson A and Alves K and Smith K and Toback S},
  year = {2023},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciac803},
  url = {https://doi.org/10.1093/cid/ciac803}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
AU  - Heath PT
AU  - Galiza EP
AU  - Baxter DN
AU  - Boffito M
AU  - Browne D
AU  - Burns F
AU  - Chadwick DR
AU  - Clark R
AU  - Cosgrove CA
AU  - Galloway J
AU  - Goodman AL
AU  - Heer A
AU  - Higham A
AU  - Iyengar S
AU  - Jeanes C
AU  - Kalra PA
AU  - Kyriakidou C
AU  - Bradley JM
AU  - Munthali C
AU  - Minassian AM
AU  - McGill F
AU  - Moore P
AU  - Munsoor I
AU  - Nicholls H
AU  - Osanlou O
AU  - Packham J
AU  - Pretswell CH
AU  - San Francisco Ramos A
AU  - Saralaya D
AU  - Sheridan RP
AU  - Smith R
AU  - Soiza RL
AU  - Swift PA
AU  - Thomson EC
AU  - Turner J
AU  - Viljoen ME
AU  - Fries L
AU  - Cho I
AU  - McKnight I
AU  - Glenn G
AU  - Rivers EJ
AU  - Robertson A
AU  - Alves K
AU  - Smith K
AU  - Toback S
PY  - 2023
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciac803
UR  - https://doi.org/10.1093/cid/ciac803
ER  -

APA

PT, H., EP, G., DN, B., M, B., D, B., F, B., DR, C., R, C., CA, C., J, G., AL, G., A, H., A, H., S, I., C, J., PA, K., C, K., JM, B., C, M., AM, M., F, M., P, M., I, M., H, N., O, O., J, P., CH, P., A, S. F. R., D, S., RP, S., R, S., RL, S., PA, S., EC, T., J, T., ME, V., L, F., I, C., I, M., G, G., EJ, R., A, R., K, A., K, S., & S, T. (2023). Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciac803

Source records